Rosuvastatin-Induced reversible rhabdomyolysis

• Váldodahkkit: Sangeeta Pradhan (Dahkki), Archita Makharia (Dahkki), Manoj Lakhotia (Dahkki), Kishan Gopal (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

We report a case of rhabdomyolysis (RM) in a postpercutaneous transluminal coronary angioplasty patient caused by a high dose of rosuvastatin. She was admitted to the hospital with complaints of muscle weakness, myalgia, and passing red-colored urine for the last 7 days. Routine blood investigations...